Richard N. Yu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sperm Retrieval | 3 | 2023 | 23 | 1.140 |
Why?
|
Sex Reassignment Surgery | 2 | 2023 | 130 | 0.900 |
Why?
|
Vesico-Ureteral Reflux | 7 | 2016 | 427 | 0.880 |
Why?
|
Sexual Development | 2 | 2021 | 34 | 0.800 |
Why?
|
Infertility, Male | 3 | 2019 | 407 | 0.780 |
Why?
|
Semen Preservation | 1 | 2019 | 35 | 0.700 |
Why?
|
Cryopreservation | 3 | 2021 | 664 | 0.660 |
Why?
|
Disorders of Sex Development | 2 | 2021 | 122 | 0.640 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2023 | 1185 | 0.570 |
Why?
|
Kidney Tubules, Collecting | 1 | 2016 | 178 | 0.540 |
Why?
|
Penis | 1 | 2016 | 216 | 0.520 |
Why?
|
Urologic Diseases | 3 | 2018 | 244 | 0.510 |
Why?
|
Health Facilities | 1 | 2020 | 573 | 0.510 |
Why?
|
Dextrans | 2 | 2006 | 592 | 0.490 |
Why?
|
Resuscitation Orders | 1 | 2016 | 267 | 0.480 |
Why?
|
Hyaluronic Acid | 2 | 2006 | 489 | 0.440 |
Why?
|
Bupivacaine | 1 | 2016 | 408 | 0.440 |
Why?
|
Sperm Banks | 1 | 2012 | 7 | 0.430 |
Why?
|
Ureter | 4 | 2016 | 374 | 0.380 |
Why?
|
Nephrectomy | 1 | 2016 | 1049 | 0.380 |
Why?
|
Semen Analysis | 1 | 2012 | 204 | 0.370 |
Why?
|
Nerve Block | 1 | 2016 | 640 | 0.360 |
Why?
|
Anesthetics, Local | 1 | 2016 | 984 | 0.340 |
Why?
|
Laparoscopy | 2 | 2017 | 2121 | 0.310 |
Why?
|
Replantation | 2 | 2016 | 148 | 0.260 |
Why?
|
Ureteroscopy | 1 | 2006 | 142 | 0.260 |
Why?
|
Klinefelter Syndrome | 2 | 2015 | 49 | 0.250 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2018 | 357 | 0.240 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.240 |
Why?
|
Microspheres | 1 | 2006 | 777 | 0.230 |
Why?
|
Colpotomy | 1 | 2022 | 14 | 0.210 |
Why?
|
Urogenital Abnormalities | 2 | 2017 | 261 | 0.210 |
Why?
|
Survivors | 1 | 2012 | 2286 | 0.200 |
Why?
|
Acetates | 1 | 2023 | 312 | 0.200 |
Why?
|
Varicocele | 1 | 2021 | 78 | 0.200 |
Why?
|
Testis | 2 | 2023 | 800 | 0.190 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2021 | 98 | 0.190 |
Why?
|
Cryptorchidism | 1 | 2021 | 123 | 0.190 |
Why?
|
Follicle Stimulating Hormone | 1 | 2023 | 738 | 0.190 |
Why?
|
Semen | 1 | 2023 | 316 | 0.190 |
Why?
|
Spermatozoa | 2 | 2023 | 625 | 0.180 |
Why?
|
Turner Syndrome | 1 | 2021 | 130 | 0.180 |
Why?
|
DNA | 1 | 2014 | 7289 | 0.180 |
Why?
|
Hypogonadism | 2 | 2017 | 798 | 0.180 |
Why?
|
Urinary Tract | 2 | 2013 | 308 | 0.170 |
Why?
|
Testosterone | 2 | 2023 | 2401 | 0.170 |
Why?
|
Adolescent | 17 | 2023 | 85649 | 0.160 |
Why?
|
Urethral Stricture | 1 | 2017 | 51 | 0.150 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2017 | 75 | 0.150 |
Why?
|
Urinary Catheterization | 1 | 2018 | 201 | 0.150 |
Why?
|
Endoscopy | 1 | 2006 | 1774 | 0.140 |
Why?
|
Stem Cells | 1 | 2009 | 3563 | 0.140 |
Why?
|
Urology | 2 | 2012 | 397 | 0.140 |
Why?
|
Catheters, Indwelling | 1 | 2018 | 425 | 0.130 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 761 | 0.130 |
Why?
|
Gels | 2 | 2006 | 427 | 0.130 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12220 | 0.130 |
Why?
|
Male | 27 | 2023 | 349538 | 0.120 |
Why?
|
Child | 16 | 2021 | 77478 | 0.120 |
Why?
|
Prostate | 1 | 2022 | 1764 | 0.110 |
Why?
|
Contraceptive Agents, Male | 1 | 2012 | 8 | 0.110 |
Why?
|
Humans | 32 | 2023 | 742088 | 0.100 |
Why?
|
Infant | 6 | 2021 | 35070 | 0.100 |
Why?
|
Clinical Competence | 2 | 2017 | 4681 | 0.100 |
Why?
|
Neoplasms | 2 | 2019 | 21596 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1679 | 0.090 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 50 | 0.090 |
Why?
|
Functional Laterality | 1 | 2017 | 2290 | 0.090 |
Why?
|
Azepines | 1 | 2012 | 336 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.090 |
Why?
|
GATA4 Transcription Factor | 1 | 2010 | 130 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 744 | 0.090 |
Why?
|
Child, Preschool | 8 | 2017 | 40955 | 0.080 |
Why?
|
Young Adult | 10 | 2022 | 56350 | 0.080 |
Why?
|
Multipotent Stem Cells | 1 | 2009 | 183 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 77098 | 0.080 |
Why?
|
Urothelium | 1 | 2010 | 277 | 0.080 |
Why?
|
Germ Cells | 1 | 2011 | 628 | 0.070 |
Why?
|
Tretinoin | 1 | 2010 | 516 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 786 | 0.070 |
Why?
|
Triazoles | 1 | 2012 | 907 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1638 | 0.070 |
Why?
|
Injections, Intralesional | 1 | 2006 | 276 | 0.070 |
Why?
|
Therapeutic Irrigation | 1 | 2006 | 300 | 0.060 |
Why?
|
Pediatrics | 2 | 2017 | 3462 | 0.060 |
Why?
|
Physician's Role | 1 | 2012 | 942 | 0.060 |
Why?
|
Urologic Surgical Procedures | 2 | 2017 | 301 | 0.060 |
Why?
|
Forecasting | 2 | 2010 | 2948 | 0.060 |
Why?
|
Injections | 1 | 2006 | 840 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5425 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.050 |
Why?
|
Pluripotent Stem Cells | 1 | 2009 | 795 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2016 | 15244 | 0.050 |
Why?
|
Orchiopexy | 1 | 2021 | 20 | 0.050 |
Why?
|
Metaplasia | 1 | 2022 | 313 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1618 | 0.050 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1760 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2527 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2011 | 3617 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2536 | 0.040 |
Why?
|
Orchiectomy | 1 | 2021 | 466 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5304 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2195 | 0.040 |
Why?
|
Urogenital System | 1 | 2018 | 86 | 0.040 |
Why?
|
Female | 15 | 2022 | 379592 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7276 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3062 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5851 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4246 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9305 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2021 | 62966 | 0.040 |
Why?
|
Vagina | 1 | 2022 | 825 | 0.040 |
Why?
|
Urination | 1 | 2017 | 204 | 0.040 |
Why?
|
Quality of Life | 1 | 2017 | 12730 | 0.030 |
Why?
|
Circumcision, Male | 1 | 2017 | 150 | 0.030 |
Why?
|
Physical Examination | 1 | 2021 | 1239 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9410 | 0.030 |
Why?
|
Radiography | 1 | 2006 | 7010 | 0.030 |
Why?
|
Adult | 7 | 2022 | 213712 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8333 | 0.030 |
Why?
|
Androgens | 1 | 2022 | 1271 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 1597 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3306 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2018 | 924 | 0.030 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2017 | 336 | 0.030 |
Why?
|
Ultrasonography | 1 | 2006 | 5978 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 780 | 0.030 |
Why?
|
Blood-Testis Barrier | 1 | 2012 | 11 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2030 | 0.030 |
Why?
|
Sperm Count | 1 | 2012 | 216 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 386 | 0.030 |
Why?
|
Psychophysiologic Disorders | 1 | 2013 | 228 | 0.020 |
Why?
|
Sperm Motility | 1 | 2012 | 253 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 123 | 0.020 |
Why?
|
Karyotyping | 1 | 2013 | 1243 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 2012 | 166 | 0.020 |
Why?
|
Somatomedins | 1 | 2011 | 192 | 0.020 |
Why?
|
Endocrinology | 1 | 2017 | 443 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40054 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 300 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3582 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2010 | 380 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 985 | 0.020 |
Why?
|
Counseling | 1 | 2017 | 1521 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
Living Donors | 1 | 2012 | 618 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2295 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2924 | 0.020 |
Why?
|
Ecosystem | 1 | 2011 | 471 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2900 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1574 | 0.020 |
Why?
|
Animals | 4 | 2012 | 168561 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3528 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3847 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5295 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53187 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3589 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4771 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 21821 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8297 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7770 | 0.010 |
Why?
|
Models, Molecular | 1 | 2012 | 5454 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25575 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7716 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39004 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2012 | 2145 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29010 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29087 | 0.010 |
Why?
|
Zebrafish | 1 | 2011 | 2990 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5975 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18355 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 3769 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5212 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10372 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
United States | 2 | 2016 | 69693 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13403 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3649 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12958 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15056 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11363 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 13029 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15530 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5100 | 0.010 |
Why?
|
Incidence | 1 | 2013 | 20928 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
Mice | 2 | 2012 | 81045 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16331 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2010 | 7873 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23320 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 40450 | 0.010 |
Why?
|
Signal Transduction | 1 | 2010 | 23387 | 0.000 |
Why?
|
Risk Factors | 1 | 2012 | 72145 | 0.000 |
Why?
|
Aged | 1 | 2017 | 162944 | 0.000 |
Why?
|
Middle Aged | 1 | 2017 | 213127 | 0.000 |
Why?
|